Innovating Localized Radiation Therapy

CivaTech Oncology® designs innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet™ can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products insure that radiation oncologists can deliver individualized, targeted therapy to treat cancer.

For Patients

Patients being treated for prostate and other cancers may benefit from the implantation of CivaTech’s unique low dose rate brachytherapy sources, available as CivaString and CivaSheet. Ask your doctor and learn more.

For Professionals

CivaTech’s novel CivaString and CivaSheet seamlessly integrate into current clinical workflows,  beginning with your usual imaging modalities, through treatment planning, and ending with post-implant dosimetry. Learn more.

News

CivaTech Oncology Announces SS&D
Registry Approved For CivaSheet™

Research Triangle Park, NC. November 3, 2014 – CivaTech Oncology, a medical device company dedicated to developing innovations in radiation therapy, announced today it has received a Registry Number as a “Sealed Source and Device” for its CivaSheet™ low dose rate (LDR) Palladium 103 source. The FDA-cleared CivaSheet™ registration was issued by the State of N.C. Division of Health Service Regulation (DHSR), Radiation Protection Sections (RPS) which is now maintained by the U.S. Nuclear Regulatory Commission (NRC) in the National Sealed Source and Device Registry (NSSDR).

The implantable CivaSheet™ is the only membrane-like brachytherapy device that is
truly customizable to a specific patient’s condition and offers a uni-directional option to shield healthy tissue.